Humana Sets New 52-Week High at $129.36 (HUM)
Humana (NYSE:HUM) shares hit a new 52-week high on Monday , AmericanBankingNews.com reports. The company traded as high as $129.36 and last traded at $128.06, with a volume of 434,183 shares trading hands. The stock had previously closed at $127.41.
A number of analysts have recently weighed in on HUM shares. Analysts at Sterne Agee initiated coverage on shares of Humana in a research note on Friday. They set a “neutral” rating and a $139.00 price target on the stock. Separately, analysts at Zacks reiterated a “neutral” rating on shares of Humana in a research note on Thursday, June 19th. They now have a $131.00 price target on the stock. Finally, analysts at Stifel Nicolaus upgraded shares of Humana from a “hold” rating to a “buy” rating in a research note on Friday, June 6th. They now have a $155.00 price target on the stock. Three research analysts have rated the stock with a sell rating, twelve have issued a hold rating and five have issued a buy rating to the company. The company presently has an average rating of “Hold” and an average price target of $125.00.
The stock has a 50-day moving average of $124.3 and a 200-day moving average of $110.2. The company has a market cap of $19.769 billion and a price-to-earnings ratio of 17.91.
Humana (NYSE:HUM) last issued its quarterly earnings data on Wednesday, May 7th. The company reported $2.35 EPS for the quarter, beating the Thomson Reuters consensus estimate of $1.94 by $0.41. During the same quarter in the prior year, the company posted $2.69 earnings per share. On average, analysts predict that Humana will post $7.83 earnings per share for the current fiscal year.
Humana Inc (NYSE:HUM) is a health care company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.